Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, optometry, and retina.
|Videos|March 11, 2022
Significance of imaging in retinal disease scans
Mohammad Rafieetary, OD, FAAO, shares highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease."
Advertisement
Mohammad Rafieetary, OD, FAAO, consultative optometric physician at the Charles Retina Institute in Germantown, Tennessee, speaks with Optometry Times®' Alex Delaney-Gesing on highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease," including why optometrists should be knowledgeable about their diagnoistic devices.
Advertisement
Related to this article
Nora Lee Cothran, OD, FAAO, reviews a study which found a statistically significant reduction in IOP in patients with open-angle glaucoma and ocular hypertension when switching to latanoprostene bunod.
Jade Coats, OD, FAAO, stopped by to discuss her presentation at AAOpt 2026, titled"How Eyelid Hygiene Can Change the Dry Eye Conversation."
Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
Neda Gioia, OD, CNS, FMCP, FOWNS, CFMP, details a lack of research exploring the intersection of hormones and ocular health in women and what health care as a whole should investigate next.
Shane Kannarr, OD, overviews results from a phase 4, multicenter, prospective, open-label trial that evaluated the impact of concomitant use of PFHO during contact lens wear.
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
Christopher W. Lievens, OD, MS, PhD, FAAO, FNAP, FBCLA, discusses his poster presentation titled "Latanoprostene bunod 0.024% Initiation in Medicare Fee-for-Service Patients with Open Angle Glaucoma and Ocular Hypertension."
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: The underutilization of latanoprostene bunod 0.024% in glaucoma care
2
AAOpt 2026: The human cost of dry eye
3
AAOpt 2026: Insights into perimenopause and presbyopia
4
Johnson & Johnson Acuvue Oasys lenses demonstrate favorable moisture retention
5